Effective chimeric antigen receptor T cells against SARS-CoV-2

Código QR

Effective chimeric antigen receptor T cells against SARS-CoV-2

Summary: Current therapies to treat coronavirus disease 2019 (COVID-19) involve vaccines against the spike protein S1 of SARS-CoV-2. Here, we outline an alternative approach involving chimeric antigen receptors (CARs) in T cells (CAR-Ts). CAR-T recognition of the SARS-CoV-2 receptor-binding domain (...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Xueyang Guo, Alexandra Kazanova, Stephanie Thurmond, H. Uri Saragovi, Christopher E. Rudd
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	Cell biology Immunology Molecular microbiology Science Q
Acceso en línea:	https://doaj.org/article/92a1ae3a31c64365ad85696fa463ec73
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Preclinical testing of chimeric antigen receptor T cells in neuroblastoma mouse models
por: Nan Li, et al.
Publicado: (2021)

The impact of viral mutations on recognition by SARS-CoV-2 specific T cells
por: Thushan I. de Silva, et al.
Publicado: (2021)

Mechanisms of Immunothrombosis by SARS-CoV-2
por: María Teresa Hernández-Huerta, et al.
Publicado: (2021)

UnCovid: A versatile, low-cost, and open-source protocol for SARS-CoV-2 RNA detection
por: Roberto Alcántara, et al.
Publicado: (2021)

MVA vector expression of SARS-CoV-2 spike protein and protection of adult Syrian hamsters against SARS-CoV-2 challenge
por: Clement A. Meseda, et al.
Publicado: (2021)

A TCR-based Chimeric Antigen Receptor
por: Even Walseng, et al.
Publicado: (2017)

Viral vector-based vaccines against SARS-CoV-2
por: Kenneth Lundstrom
Publicado: (2021)

Human endogenous retrovirus-enveloped baculoviral DNA vaccines against MERS-CoV and SARS-CoV2
por: Hansam Cho, et al.
Publicado: (2021)

5T4-specific chimeric antigen receptor modification promotes the immune efficacy of cytokine-induced killer cells against nasopharyngeal carcinoma stem cell-like cells
por: Xueyang Guo, et al.
Publicado: (2017)

The possible role of molecular mimicry in SARS-CoV-2-mediated autoimmunity: an immunobiochemical basis
por: Dženan Kovačić, et al.
Publicado: (2021)

Highly Specific Sigma Receptor Ligands Exhibit Anti-Viral Properties in SARS-CoV-2 Infected Cells
por: David A. Ostrov, et al.
Publicado: (2021)

Chimeric antigen receptor modified T-cells for cancer treatment
por: Xiao Han, et al.
Publicado: (2018)

Natural Products-Based Drug Design against SARS-CoV-2 Mpro 3CLpro
por: Rai C. Silva, et al.
Publicado: (2021)

Immune response against SARS-CoV-2 variants: the role of neutralization assays
por: Alicja Maria Chmielewska, et al.
Publicado: (2021)

Potential of Marine Terpenoids against SARS-CoV-2: An <i>In Silico</i> Drug Development Approach
por: Alaka Sahoo, et al.
Publicado: (2021)

Polyclonal F(ab’)2 fragments of equine antibodies raised against the spike protein neutralize SARS-CoV-2 variants with high potency
por: Luis Eduardo R. Cunha, et al.
Publicado: (2021)

Molecular docking and dynamics studies on propolis sulabiroin-A as a potential inhibitor of SARS-CoV-2
por: Jaka Fajar Fatriansyah, et al.
Publicado: (2022)

Enhanced protective immunity against SARS-CoV-2 elicited by a VSV vector expressing a chimeric spike protein
por: Hongyue Li, et al.
Publicado: (2021)

Naturally Available Flavonoid Aglycones as Potential Antiviral Drug Candidates against SARS-CoV-2
por: Ahmed A. Al-Karmalawy, et al.
Publicado: (2021)

New Acaciin-Loaded Self-Assembled Nanofibers as MPro Inhibitors Against BCV as a Surrogate Model for SARS-CoV-2
por: Mohamad SA, et al.
Publicado: (2021)

An Early Pandemic Analysis of SARS-CoV-2 Population Structure and Dynamics in Arizona
por: Jason T. Ladner, et al.
Publicado: (2020)

Mucosal vaccination induces protection against SARS-CoV-2 in the absence of detectable neutralizing antibodies
por: Chaojie Zhong, et al.
Publicado: (2021)

Correlation of N-glycan dynamics and interaction network with allosteric antigen binding and Fc receptor recognition
por: Buyong Ma
Publicado: (2021)

Structural engineering of chimeric antigen receptors targeting HLA-restricted neoantigens
por: Michael S. Hwang, et al.
Publicado: (2021)

Clinically compliant spatial and temporal imaging of chimeric antigen receptor T-cells
por: Nia Emami-Shahri, et al.
Publicado: (2018)

An Interesting Similarity of Bacillus Calmette-Guerin and Chimeric Antigen Receptor T Cells
por: Seyed Saeed Tamehri Zadeh, et al.
Publicado: (2020)

Noncanonical protease-activated receptor 1 regulates lymphatic differentiation in zebrafish
por: Daoxi Lei, et al.
Publicado: (2021)

Desensitized chimeric antigen receptor T cells selectively recognize target cells with enhanced antigen expression
por: Chungyong Han, et al.
Publicado: (2018)

The role of protease-activated receptor 1 signaling in CD8 T cell effector functions
por: Hui Chen, et al.
Publicado: (2021)

Development and Characterization of Magnetic SARS-CoV-2 Peptide-Imprinted Polymers
por: Beatriz Fresco-Cala, et al.
Publicado: (2021)

Comparative systematic review and meta-analysis of reactogenicity, immunogenicity and efficacy of vaccines against SARS-CoV-2
por: Ian McDonald, et al.
Publicado: (2021)

Anti-BCMA chimeric antigen receptors with fully human heavy-chain-only antigen recognition domains
por: Norris Lam, et al.
Publicado: (2020)

A Multiallelic Molecular Beacon-Based Real-Time RT-PCR Assay for the Detection of SARS-CoV-2
por: Andreas C. Chrysostomou, et al.
Publicado: (2021)

Potential role of nicotinamide analogues against SARS-COV-2 target proteins
por: Mandeep Kumar Arora, et al.
Publicado: (2021)

Efficacy of anti-CD147 chimeric antigen receptors targeting hepatocellular carcinoma
por: Hsiang-chi Tseng, et al.
Publicado: (2020)

Cell Therapy for Colorectal Cancer: The Promise of Chimeric Antigen Receptor (CAR)-T Cells
por: Cristina Aparicio, et al.
Publicado: (2021)

Human herpesvirus 6 myelitis after chimeric antigen receptor T-cell therapy
por: Guy Handley, et al.
Publicado: (2021)

Rapid antigen tests for the detection of SARS-CoV-2: A comment
por: Pathum Sookaromdee, et al.
Publicado: (2022)

Tear antibodies to SARS‐CoV‐2: implications for transmission
por: Kevin J Selva, et al.
Publicado: (2021)

Predicted Epitope Abundance Supports Vaccine-Induced Cytotoxic Protection Against SARS-CoV-2 Variants of Concern
por: Antonio J. Martín-Galiano, et al.
Publicado: (2021)